Multiple sclerosis   

Does JC Virus Ab status play a role in your decision?

Is it necessary to do a taper afterward and what would be the recommended tapering schedule/duration? 

Is it dependent on which DMT the patient is on?

Are there emerging biomarkers that help distinguish the phenotypes in the absence of evaluation over time?

E.g., JC virus antibody titer, absolute lymphocyte count, etc.

Are there contraindications to drugs like oxaliplatin or abraxane? Does chronicity or severity of the patient's underlying symptoms play a role in yo...